Key Record Dates
ClinicalTrials.gov Identifier: | NCT05881408 |
---|---|
Brief Title: | A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Non-Ambulatory and Ambulatory Participants With Duchenne Muscular Dystrophy (DMD) (ENVISION) |
First Submitted : | May 19, 2023 |
First Submitted that Met QC Criteria : | May 19, 2023 |
First Posted : | May 31, 2023 |
Last Update Submitted that Met QC Criteria : | March 22, 2024 |
Last Update Posted : | March 25, 2024 |